The 2025 Sydney Film Festival reminded me: there is nothing like a bunch of strangers assembling in the dark

| Insights & Views

In an era of the atomisation of viewing practices through streaming, increasingly short, self-produced videos for TikTok and YouTube, and the reduction of all audiovisual material to content for various platforms, there is...

Why is there so much concern over Iran’s nuclear program? And where could it go from here?

| Insights & Views

Conflict between Israel and Iran is intensifying, after Israeli airstrikes on key nuclear sites and targeted assassinations last week were followed by counter-strikes by Iran on Israel. These attacks have come at a moment...

Regime change wouldn’t likely bring democracy to Iran. A more threatening force could fill the vacuum

| Insights & Views

The timing and targets of Israels attacks on Iran tell us that Prime Minister Benjamin Netanyahus short-term goal is to damage Irans nuclear facilities in order to severely diminish its weapons program. But Netanyahu has...

There’s a new ban on vaping in childcare centres, but what else do we need to keep kids safe?

| Insights & Views

On Monday, the federal government announced new rules to boost safety in the early childhood sector. From September there will be mandatory reporting of any allegations or incidents of child physical or sexual abuse within...

View from the Hill: Cancelled Albanese-Trump meeting a setback on tariffs, AUKUS

| Insights & Views

Anthony Albaneses failure to get his much-anticipated meeting with US President Donald Trump is not the prime ministers fault, nor should it be characterised as a snub by the president. There was always a risk of...

The hidden bias in college admissions tests: How standardized exams can favor privilege over potential

| Insights & Views

At first glance, calls from members of Congress to restore academic merit in college admissions might sound like a neutral policy. In our view, these campaigns often cherry-pick evidence and mask a coordinated effort that...

When developing countries band together, lifesaving drugs become cheaper and easier to buy − with trade-offs

| Insights & Views

Procuring lifesaving drugs is a daunting challenge in many low- and middle-income countries. Essential treatments are often neither available nor affordable in these nations, even decades after the drugs entered the...